<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566447</url>
  </required_header>
  <id_info>
    <org_study_id>TV-01-2015</org_study_id>
    <nct_id>NCT02566447</nct_id>
  </id_info>
  <brief_title>&quot;Solana™ Trichomonas Assay Field Study&quot;</brief_title>
  <official_title>&quot;Solana™ Trichomonas Assay Field Study&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Quidel Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Quidel Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Solana® Trichomonas Assay is an in vitro qualitative nucleic acid amplification test for
      the detection of Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the
      Helicase-Dependent Amplification (HDA) technology and the Solana instrument.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to establish the clinical performance of the Solana® Trichomonas Assay for the
      detection of Trichomonas vaginalis in vaginal swabs and urine samples as compared to a
      combined reference method of direct wet mount microscopy and a FDA-cleared device.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2015</start_date>
  <completion_date type="Actual">August 15, 2016</completion_date>
  <primary_completion_date type="Actual">August 15, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Trichomonas Test Result</measure>
    <time_frame>2 days</time_frame>
    <description>Testing results will be received by testing site for current FDA cleared tests</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">750</enrollment>
  <condition>Trichomonas Vaginalis</condition>
  <arm_group>
    <arm_group_label>Symptomatic</arm_group_label>
    <description>Subjects will be categorized by the clinician as symptomatic for Trichomonas vaginalis infection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Solana Trichomonas Assay Testing</intervention_name>
    <description>Specimen collection of urine and/or vaginal swabs for testing</description>
    <arm_group_label>Symptomatic</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Trichomonas vaginalis in vaginal swabs and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects symptomatic for Trichomonas vaginalis infection.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female subjects will be recruited from the general population as they present to the
             clinical facility. Subjects will be categorized by the clinician as either
             asymptomatic or symptomatic for Trichomonas vaginalis infection.

        Symptoms in women can include:

          -  Greenish-yellow, frothy vaginal discharge with a strong odor

          -  Painful urination

          -  Vaginal itching and irritation

          -  Discomfort during intercourse

          -  Lower abdominal pain (rare)

        Exclusion Criteria:

          1. The study is limited to females. Male subjects are not accepted.

          2. At clinical sites informed consent, unable to understand and consent to participation;
             for minors this includes parent or legal guardian.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Div. of Infectious Diseases</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington in Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trichomonas Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

